Jefferies analyst Akash Tewar raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Jefferies sees up to 90% chance Horizon Therapeutics (HZNP) gets acquired, with $125 base caseDecember 1, 2022 11:06 AM